radiuspharm.com (RDUS): Dana dhuwit perusahaan

Tandha merek Radius Recycling (RDUS)

The Radius Recycling, Inc. (RDUS) operating model relies on external partners for research, keeping the corporate structure lean. The cash balance history demonstrates liquidity dynamics, where 0.02 determines the latest valuation metric. The business benefits from the cyclical nature of scrap metal collection, ensuring consistent turnover. The current financial position remains stable, allowing the company to easily cover its obligations and capital expenditures.

RDUS - Volume dana dhuwit perusahaan Radius Recycling Inc. ing rentang 04.07.2022 - 26.07.2025

Rincian analitis lan laporan data perusahaan Radius Health (RDUS)

- nilai saham lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:RDUS radiuspharm.com
Produk merek Radius Recycling Inc.

Liquid asset volume is generated by the difference between operating income and capital expenditures. This metric measures the financial stability and the ability of the issuer to cover obligations without incurring external debt. For Radius Recycling, Inc. (RDUS), such reserves are critical when implementing robotic bioscreening systems and laboratory automation. Analyzing the cash balance allows for an assessment of the pace of technological upgrades. The trend of this indicator determines the business's readiness to scale innovations.

Pesaing utama

Dana dhuwit perusahaan ascendispharma.com (ASND)|Dhuwit awis perusahaan madrigalpharma.com MDGL|Volume dana dhuwit perusahaan CORT (Corcept Therapeutics Inc.)|Sisa dhuwit perusahaan RYTM|AKRO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Metsera Inc|MoonLake Immunotherapeutics AG (MLTX) - Dana dhuwit perusahaan|CRNX - Aset likuid perusahaan|NAMS (newamsterdampharma.com) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Soleno Therapeutics Inc SLNO|Dhuwit awis perusahaan FOLD (Amicus Therapeutics Inc)|ETNB (89bio Corp) - Sisa dhuwit perusahaan|Agios Pharmaceuticals - Dhuwit awis perusahaan|Gunggung dana dhuwit perusahaan GPCR (Structure Therapeutics Inc.)|MDXG: Dhuwit awis perusahaan|Rezolute - Gunggung dana dhuwit perusahaan|LXRX (Lexicon Pharma) - Dhuwit awis perusahaan|Dhuwit awis perusahaan MBX Bio|Dhuwit awis perusahaan ALT|AARD: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SGMT|Dana dhuwit perusahaan BIOA (BioAge Labs)|Volume dana dhuwit perusahaan BMEA (Biomea Fusion Corp)|Sisa dhuwit perusahaan QNCX|GUTS - Dana dhuwit perusahaan|VTVT - Volume dana dhuwit perusahaan|Agape ATP Corp. (ATPC) - Dana dhuwit perusahaan|Pluri Inc (PLUR) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Synlogic|Dana dhuwit perusahaan LPCN|Dana dhuwit perusahaan Matinas BioPharma Holdings, Inc. (MTNB)|Spruce Biosciences - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Galecto Corporation GLTO|Gunggung dana dhuwit perusahaan CTCX (Carmell)|LUMO: Dhuwit awis perusahaan|Aset likuid perusahaan Organovo Holdings, Inc. ONVO